Millwright Xxxxx be to assist and work under the direction and instructions I or A. He will work alone at times performing assignments in keeping with his training. During the course of his year, training must become proficient in good practices in the areas of fitting, aligning, lubricating and the operation of all shop tools and machines. In addition to the foregoing, he will be exposed to and the process of learning techniques required in trouble shooting key production machinery, pipe fitting, basic welding and machining but not be expected to display a high degree of proficiency in these areas at this point. Millwright Must be capable of performing the tasks of fittings, aligning, lubricating an able to operate all shop tools and machines. Must under direction become proficient in basic welding and pipe fitting as well as dismantling and reassembly of plant equipment. Under direction,will continueto develop skills in trouble shooting all plant equipment and improve his skills at machining part and be exposed to basic principles of hydraulics and pneumatic. He may work alone frequently, but occasionally will require direction and instructions form Millwright I or A. Millwright 11: be capable, without direction of fitting, aligning and lubrication and taking apart and reassembling plant equipment. In addition, is expected to be able to weld, operate shop tools and do pipe fitting as required. Must under direction, become proficient at effective methods of trouble shooting and repairing hydraulic, pneumatic and mechanical faults in plant machinery. I: Must be capable without direction of performing all practices under Xxxxxxxxxx Must under directionbecomeproficient at reading and understanding blueprints, all phases of installing new equipment, laying out hydraulic and mechanical drives and meet speed and power requirements correctly. Xxxxxxxxxx "A": Must he capable without direction, of performing all under Xxxxxxxxxx X, and Must take full responsibility for work done by himself or his assistant. Must he in possession of a Millwright Certificate or a Machinist Certificate or Welder Certificate. Millwrightspresently employed in this classification will not be required to have a Certificate.
Datenschutzrichtlinie Ihre Informationen werden jederzeit gemäß der Apple Datenschutzrichtlinie behandelt, die durch Verweis in diese Lizenz integriert wird und unter folgender Adresse verfügbar ist: xxxx://xxx.xxxxx.xxx/de/privacy/.
Oddělitelnost Pokud bude jakékoliv ustanovení, právo nebo nápravný prostředek uvedený v této Smlouvě shledán soudem příslušné jurisdikce nevynutitelným nebo neúčinným, nebude tím ovlivněna platnost a vynutitelnost zbývajících ustanovení.
Brakes Master cylinder, wheel cylinders, hydraulic lines and fittings, power booster and brake callipers. Excludes linings, pads, drums and discs.
Sch A-13 MONEY MARKET FUNDS ------------------ Active Assets California Tax-Free Trust 05/31/97, as amended on 0.45% of the portion of the daily net assets not 04/30/98 exceeding $500 million; 0.375% of the portion of the daily net assets exceeding $500 million but not exceeding $750 million; 0.325% of the portion of the daily net assets exceeding $750 million but not exceeding $1 billion; 0.30% of the portion of the daily net assets exceeding $1 billion but not exceeding $1.5 billion; 0.275% of the portion of the daily net assets exceeding $1.5 billion but not exceeding $2 billion; 0.25% of the portion of the daily net assets exceeding $2 billion but not exceeding $2.5 billion; 0.225% of the portion of the daily net assets exceeding $2.5 billion but not exceeding $3 billion; and 0.20% of the portion of the daily net assets exceeding $3 billion Active Assets Government Securities 05/31/97, as amended on 0.45% of the portion of the daily net assets not Trust 04/30/98 exceeding $500 million; 0.375% of the portion of the daily net assets exceeding $500 million but not exceeding $750 million; 0.325% of the portion of the daily net assets exceeding $750 million but not exceeding $1 billion; 0.30% of the portion of the daily net assets exceeding $1 billion but not exceeding $1.5 billion; 0.275% of the portion of the daily net assets exceeding $1.5 billion but not exceeding $2 billion; 0.25% of the portion of the daily net assets exceeding $2 billion but not exceeding $2.5 billion; 0.225% of the portion of the daily net assets exceeding $2.5 billion but not exceeding $3 billion; and 0.20% of the portion of the daily net assets exceeding $3 billion. Active Assets Institutional Government 03/08/02 0.10% of the daily net assets. Securities Trust On an ongoing basis, the Investment Adviser has agreed under this Agreement with the Fund to assume Fund operating expenses (except for brokerage fees) to the extent that such operating expenses exceed on an annualized basis 0.20% of the average daily net assets of the Fund. This may reduce the fees under this Agreement and the Administration Agreement below 0.15% for the Fund. Sch.A-14 MONEY MARKET FUNDS ------------------ Active Assets Institutional Money Trust 01/06/00 0.10% of the daily net assets. On an ongoing basis, the Investment Adviser has agreed under this Agreement with the Fund to assume Fund operating expenses (except for brokerage fees) to the extent that such operating expenses exceed on an annualized basis 0.20% of the average daily net assets of the Fund. This may reduce the fees under this Agreement and the Administration Agreement below 0.15% for the Fund. Active Assets Money Trust 05/31/97, as amended on 0.45% of the portion of the daily net assets not 04/30/98, 05/01/99, 05/01/01, exceeding $250 million; 0.375% of the portion of the 05/01/02 daily net assets exceeding $250 million but not exceeding $750 million; 0.325% of the portion of the daily net assets exceeding $750 million but not exceeding $1.25 billion; 0.30% of the portion of the daily net assets exceeding $1.25 billion but not exceeding $1.5 billion; 0.275% of the portion of the daily net assets exceeding $1.5 billion but not exceeding $1.75 billion; 0.25% of the portion of the daily net assets exceeding $1.75 billion but not exceeding $2.25 billion; 0.225% of the portion of the daily net assets exceeding $2.25 billion but not exceeding $2.75 billion; 0.20% of the portion of the daily net assets exceeding $2.75 billion but not exceeding $15 billion; 0.199% of the portion of the daily net assets exceeding $15 billion but not exceeding $17.5 billion; 0.198% of the portion of the daily net assets exceeding $17.5 billion but not exceeding $25 billion; 0.197% of the portion of the daily net assets exceeding $25 billion but not exceeding $30 billion; and 0.196% of the portion of the daily net assets exceeding $30 billion. Active Assets Tax-Free Trust 05/31/97, as amended on 0.45% of the portion of the daily net assets not 04/30/98 exceeding $500 million; 0.375% of the portion of the daily net assets exceeding $500 million but not exceeding $750 million; 0.325% of the portion of the daily net assets exceeding $750 million but not exceeding $1 billion; 0.30% of the portion of the daily net assets exceeding $1 billion but not exceeding $1.5 billion; 0.275% of the portion of the daily net assets exceeding $1.5 billion but not Sch.A-15 MONEY MARKET FUNDS ------------------ exceeding $2 billion; 0.25% of the portion of the daily net assets exceeding $2 billion but not exceeding $2.5 billion; 0.225% of the portion of the daily net assets exceeding $2.5 billion but not exceeding $3 billion; 0.20% of the portion of the daily net assets exceeding $3 billion but not exceeding $15 billion; and 0.199% of the portion of daily net assets exceeding $15 billion. Morgan Stanley California Tax- Xxxx 00/31/97, as amended on 0.45% of the portion of the daily net assets not Daily Income Trust 04/30/98 exceeding $500 million; 0.375% of the portion of the daily net assets exceeding $500 million but not exceeding $750 million; 0.325% of the portion of the daily net assets exceeding $750 million but not exceeding $1 billion; 0.30% of the portion of the daily net assets exceeding $1 billion but not exceeding $1.5 billion; 0.275% of the portion of the daily net assets exceeding $1.5 billion but not exceeding $2 billion; 0.25% of the portion of the daily net assets exceeding $2 billion but not exceeding $2.5 billion; 0.225% of the portion of the daily net assets exceeding $2.5 billion but not exceeding $3 billion; and 0.20% of the portion of the daily net assets exceeding $3 billion. Morgan Stanley Liquid Asset Funx Xxx. 00/31/97, as amended on 0.45% of the portion of the daily net assets not (Maryland Corporation) 04/30/98, 05/01/01, 05/01/02 exceeding $250 million; 0.375% of the portion of the daily net assets exceeding $250 million but not exceeding $750 million; 0.325% of the portion of the daily net assets exceeding $750 million but not exceeding $1.25 billion; 0.30% of the portion of the daily net assets exceeding $1.25 billion but not exceeding $1.5 billion; 0.275% of the portion of the daily net assets exceeding $1.5 billion but not exceeding $1.75 billion; 0.25% of the portion of the daily net assets exceeding $1.75 billion but not exceeding $2.25 billion; 0.225% of the portion of the daily net assets exceeding $2.25 billion but not exceeding $2.75 billion; 0.20% of the portion of the daily net assets exceeding $2.75 billion but not exceeding $15 billion; 0.199% of the portion of the daily net assets exceeding $15 billion but not exceeding $17.5 billion; 0.198% of the portion of the daily net assets exceeding $17.5 billion but not exceeding $25 billion; 0.197% of the portion of the daily net assets exceeding Sch.A-16
Legionella Legionella means any discharge release or escape of legionella or other airborne pathogens from water tanks, water systems, air-conditioning plants, cooling towers and the like.
Yleistä A. Apple-ohjelmisto ja muiden valmistajien ohjelmat, dokumentaatio, käyttöliittymät, sisältö, fontit ja muu tämän Lisenssin mukana tuleva tieto, olipa xx xxxxxx kirjoitussuojatussa muistissa, millä tahansa muulla medialla tai missä tahansa muussa muodossa (yhteisnimitykseltään ”Apple-ohjelmisto”) on lisensoitu, ei myyty, sinulle Apple Inc:n (”Apple”) toimesta käytettäväksi ainoastaan tämän Lisenssin ehtojen mukaisesti. Apple ja/xxx Xxxxxx lisensoijat säilyttävät omistajuutensa Apple-ohjelmistoon ja pidättävät itsellään kaikki oikeudet, joita ei ole erikseen annettu sinulle.
Záznamy The Institution and the Investigator shall maintain accurate, complete and current records of all Study Data, including the Case Report Forms (or equivalent electronic data), relevant source documents and any other essential documents or materials as required by the Protocol, the Applicable Regulatory Requirements and PSI’s and the Sponsor’s instructions (collectively the "Records"). The Institution and the Investigator shall keep all the Records in a safe and secure location for the period required by the Applicable Regulatory Requirements, or for a period of fifteen (15) years following the completion of the Study, whichever is longer. The Institution and/or the Investigator may destroy the Records at the end of the Records keeping period on the condition that the Institution and/or the Investigator sends written notice to the Sponsor at least sixty (60) days prior to the date deletion/disposal will occur, and, if requested by the Sponsor, cooperates with the Sponsor in extending the Record keeping period or shipping the Records to another facility for storage, at the Sponsor’s reasonable expense. Zdravotnické zařízení a Hlavní zkoušející povedou přesné, úplné a aktuální záznamy o všech Studijních údajích, které budou zahrnovat Záznamy subjektů hodnocení (nebo odpovídající údaje v elektronické podobě), příslušné zdrojové dokumenty a jakékoli další nezbytné dokumenty nebo materiály dle požadavků Protokolu, Platných regulačních požadavků a pokynů PSI a Zadavatele (dále jen „Záznamy“). Zdravotnické zařízení a Hlavní zkoušející budou Záznamy uchovávat na bezpečném a zabezpečením místě xx xxxx xxxxxxxxxxx Xxxxxxxx regulačními požadavky nebo po dobu patnácti (15) let od dokončení Studie (kterákoli doba bude delší). Zdravotnické zařízení a/nebo Hlavní zkoušející mohou Záznamy po uplynutí lhůty pro uchovávání Záznamů zlikvidovat za podmínky, že Zdravotnické zařízení a/nebo Hlavní zkoušející zašlou Zadavateli oznámení alespoň šedesát (60) dnů před datem vymazání/likvidace Záznamů a na žádost Zadavatele s ním budou spolupracovat na prodloužení lhůty pro uchovávání Záznamů nebo zaslání Záznamů do jiného zařízení, kde budou uloženy, a to na přiměřené náklady Zadavatele.
moorditj kwabadak Healthy people refers to the commitment we have as an organisation to ensure our staff, patients and the wider community have access to comprehensive healthcare services, in order to maintain healthy lives. Amazing care reflects the sentiment of those consumers accessing our healthcare services from feedback provided to us. This common statement resonates with the health service, and reflects our intentions in our practice and work every day. As a health service which celebrates diversity of culture and languages, it is also important that our vision is shared in the Noongar language. Our Values Our Values reflect the qualities that we demonstrate to each other and our community every day. Our staff make a difference every day to the patients, families and consumers they provide care, advice and support to. The EMHS values capture the shared responsibility that we uphold as most important, which are: • Kindness – kindness is represented in the support that we give to one another. This is how we demonstrate genuine care and compassion to each and every person.
Definice „Důvěrné informace“ budou vykládány jako informace důvěrné a majetkové povahy náležející Zadavateli, přičemž budou zahrnovat (i) veškeré informace, jež byly Zdravotnickému zařízení, Zkoušejícímu či kterémukoli členu personálu Zdravotnického zařízení, poskytnuty, odhaleny, zpřístupněny či sděleny Zadavatelem či jeho jménem, zejména včetně informací o Hodnoceném léčivu, technických informací vztahujících se k Hodnocenému léčivu, veškeré Existující duševní vlastnictví (ve smyslu definice uvedené v Článku 4) Zadavatele, a Protokol; a (ii) informace vztahující se k procesu zařazování do Studie, informace vztahující se k aktuálnímu stavu Studie, komunikace vůči a od regulatorních úřadů, informace vztahující se k aktuálnímu stavu Hodnoceného léčiva na regulatorní úrovni a Studijních dat a údajů, a xxxx k Objevům (ve smyslu definice uvedené v Článku 4). Pojem Důvěrné informace nezahrnuje informace, ve vztahu ke kterým: na základě příslušné dokumentace lze prokázat, že byly veřejně známé před okamžikem či po okamžiku jejich odhalení, zpřístupnění či sdělení ze strany Zadavatele, aniž by xxx xxxxx k jakémukoli protiprávnímu jednání či opominutí přičitatelnému Zkoušejícímu, Zdravotnickému zařízení či jakémukoli jejich zaměstnanci; na základě příslušné dokumentace lze prokázat, že byly v dispozici Zkoušejícího, Zdravotnického zařízení či jakéhokoli zaměstnance před jejich zveřejněním, sdělením či zpřístupněním ze strany Zadavatele, a byly získány ze zdrojů odlišných od Zadavatele, přičemž tyto nebyly vázány povinností důvěrnosti vůči Zadavateli; na základě příslušné dokumentace lze prokázat, že byly vyvinuty nezávisle Zkoušejícím, Zdravotnickým zařízením či jakýmkoli jejich zaměstnancem; nebo jejich odhalení, zpřístupnění či sdělení lze provést na základě písemného svolení Zadavatele.
